These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3057807)

  • 21. Oxandrolone increases final height in Turner syndrome.
    Crock P; Werther GA; Wettenhall HN
    J Paediatr Child Health; 1990 Aug; 26(4):221-4. PubMed ID: 2257185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxandrolone therapy for children with Turner syndrome.
    Rosenfield RL; Lucky AW
    J Pediatr; 1977 Nov; 91(5):854-6. PubMed ID: 909038
    [No Abstract]   [Full Text] [Related]  

  • 23. Turner syndrome.
    Ranke MB
    Eur J Endocrinol; 1999 Sep; 141(3):216-7. PubMed ID: 10474117
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possibilities to increase the efficacy of growth hormone therapy in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 1997 Jun; 138(23):1501-5. PubMed ID: 9254366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height.
    Rosenfeld RG; Attie KM; Frane J; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM; Mahoney CP; Moore WV; Saenger P; Johanson AJ
    J Pediatr; 1998 Feb; 132(2):319-24. PubMed ID: 9506648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comments on 'Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome' by Zeger et al., pp. 39-47, this issue.
    Menke LA; Sas TC; Wit JM
    Horm Res Paediatr; 2011; 75(1):47-8. PubMed ID: 21051854
    [No Abstract]   [Full Text] [Related]  

  • 27. Growth hormone therapy in Turner syndrome.
    Davenport ML
    Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():723-4. PubMed ID: 22946284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
    Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome?
    Joss EE; Mullis PE; Werder EA; Partsch CJ; Sippell WG
    Horm Res; 1997; 47(3):102-9. PubMed ID: 9050948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.
    Massarano AA; Brook CG; Hindmarsh PC; Pringle PJ; Teale JD; Stanhope R; Preece MA
    Arch Dis Child; 1989 Apr; 64(4):587-92. PubMed ID: 2751332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome.
    Pasquino AM; Passeri F; Pucarelli I; Segni M; Municchi G
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1810-3. PubMed ID: 9177387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth and maturation of patients with Turner's syndrome.
    Park E; Bailey JD; Cowell CA
    Pediatr Res; 1983 Jan; 17(1):1-7. PubMed ID: 6835711
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term treatment with growth hormone has no persisting effect on lipoprotein(a) in patients with Turner's syndrome.
    Querfeld U; Döpper S; Gradehand A; Kiencke P; Wahn F; Zeisel HJ
    J Clin Endocrinol Metab; 1999 Mar; 84(3):967-70. PubMed ID: 10084580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results from the first 2 years of a clinical trial with recombinant DNA-derived human growth hormone (somatrem) in Turner's syndrome.
    Rosenfeld RG; Hintz RL; Johanson AJ; Sherman B
    Acta Paediatr Scand Suppl; 1987; 331():59-69. PubMed ID: 3300157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E; Mazzanti L
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of anabolic steroids. VI. Effect of prolonged administration of oxandrolone on growth in children and adolescents with gonadal dysgenesis.
    Moore DC; Tattoni DS; Ruvalcaba RH; Limbeck GA; Kelley VC
    J Pediatr; 1977 Mar; 90(3):462-6. PubMed ID: 190369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal therapy in a patient with a delayed diagnosis of Turner's syndrome.
    Gawlik A; Malecka-Tendera E
    Nat Clin Pract Endocrinol Metab; 2008 Mar; 4(3):173-7. PubMed ID: 18227816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of anabolic steroids. 3. The effect of oxandrolone on height and skeletal maturation in mongoloid children.
    Ray CG; Kirschvink JF; Waxman SH; Kelley VC
    Am J Dis Child; 1965 Dec; 110(6):618-23. PubMed ID: 4284784
    [No Abstract]   [Full Text] [Related]  

  • 40. Turner's syndrome, anorexia nervosa, and anabolic steroids.
    Nicholls D; Stanhope R
    Arch Dis Child; 1998 Jul; 79(1):94. PubMed ID: 9771263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.